Dual-mode hepatoprotective nanoplatform combines ROS scavenging and FGF21 activation for precision acute liver injury therapy.
- DOI
- 10.1016/j.apsb.2026.03.005
- Published
- 2026 Nov
- Container
- Acta pharmaceutica Sinica. B
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.apsb.2026.03.005,
title = {Dual-mode hepatoprotective nanoplatform combines ROS scavenging and FGF21 activation for precision acute liver injury therapy.},
author = {Tan X and Li M and Lan Z and Zhang W and Zou J and An Y and Zheng J and Xiang X and Lin J and Lin S and Ni W and Che L and Liu G and Chen J and Lu Z},
year = {2026},
journal = {Acta pharmaceutica Sinica. B},
doi = {10.1016/j.apsb.2026.03.005},
url = {https://doi.org/10.1016/j.apsb.2026.03.005}
}RIS
TY - JOUR TI - Dual-mode hepatoprotective nanoplatform combines ROS scavenging and FGF21 activation for precision acute liver injury therapy. AU - Tan X AU - Li M AU - Lan Z AU - Zhang W AU - Zou J AU - An Y AU - Zheng J AU - Xiang X AU - Lin J AU - Lin S AU - Ni W AU - Che L AU - Liu G AU - Chen J AU - Lu Z PY - 2026 JO - Acta pharmaceutica Sinica. B DO - 10.1016/j.apsb.2026.03.005 UR - https://doi.org/10.1016/j.apsb.2026.03.005 ER -
APA
X, T., M, L., Z, L., W, Z., J, Z., Y, A., J, Z., X, X., J, L., S, L., W, N., L, C., G, L., J, C., & Z, L. (2026). Dual-mode hepatoprotective nanoplatform combines ROS scavenging and FGF21 activation for precision acute liver injury therapy.. Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2026.03.005
Source records
- pubmed · retrieved 2026-11-10T10:26:03.004Z
- europe-pmc · retrieved 2026-11-10T10:26:02.991Z